Evotec SE (OTCMKTS:EVTCY - Get Free Report)'s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.17 and traded as low as $3.84. Evotec shares last traded at $4.03, with a volume of 153,406 shares changing hands.
Evotec Stock Performance
The firm has a market cap of $1.41 billion, a price-to-earnings ratio of 10.43 and a beta of 0.98. The firm's 50 day moving average is $3.74 and its 200-day moving average is $4.18. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.
Evotec Company Profile
(
Get Free Report)
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
See Also
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
